Amedisys Return on Tangible Equity 2010-2024 | AMED

Current and historical return on tangible equity values for Amedisys (AMED) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Amedisys Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-03-31 $-0.02B $-0.20B 8.61%
2023-12-31 $-0.01B $-0.23B 4.07%
2023-09-30 $0.00B $-0.26B -1.16%
2023-06-30 $0.00B $-0.29B -1.09%
2023-03-31 $0.11B $-0.21B -38.63%
2022-12-31 $0.12B $-0.28B -38.40%
2022-09-30 $0.12B $-0.32B -37.57%
2022-06-30 $0.14B $-0.36B -42.22%
2022-03-31 $0.19B $-0.29B -69.08%
2021-12-31 $0.21B $-0.33B -81.32%
2021-09-30 $0.22B $-0.36B -98.54%
2021-06-30 $0.25B $-0.13B -124.43%
2021-03-31 $0.20B $-0.21B -83.82%
2020-12-31 $0.18B $-0.20B -85.58%
2020-09-30 $0.17B $-0.26B -89.54%
2020-06-30 $0.13B $-0.30B -84.45%
2020-03-31 $0.13B $-0.11B -107.11%
2019-12-31 $0.13B $-0.08B -90.71%
2019-09-30 $0.13B $-0.12B -136.59%
2019-06-30 $0.12B $-0.16B -291.12%
2019-03-31 $0.12B $-0.19B 1394.29%
2018-12-31 $0.12B $0.11B 115.69%
2018-09-30 $0.09B $0.08B 77.51%
2018-06-30 $0.07B $0.04B 53.89%
2018-03-31 $0.04B $0.18B 27.05%
2017-12-31 $0.03B $0.15B 20.58%
2017-09-30 $0.04B $0.16B 30.82%
2017-06-30 $0.04B $0.13B 30.12%
2017-03-31 $0.05B $0.14B 38.02%
2016-12-31 $0.04B $0.13B 35.07%
2016-09-30 $0.04B $0.12B 40.80%
2016-06-30 $0.04B $0.10B 34.78%
2016-03-31 $0.04B $0.08B 31.80%
2015-12-31 $-0.00B $0.11B -2.29%
2015-09-30 $-0.01B $0.15B -4.84%
2015-06-30 $-0.01B $0.14B -4.90%
2015-03-31 $-0.01B $0.13B -7.12%
2014-12-31 $0.01B $0.16B 9.40%
2014-09-30 $-0.01B $0.14B -4.61%
2014-06-30 $-0.11B $0.13B -83.17%
2014-03-31 $-0.11B $0.12B -75.64%
2013-12-31 $-0.10B $0.13B -57.14%
2013-09-30 $-0.19B $0.13B -103.90%
2013-06-30 $-0.09B $0.21B -47.85%
2013-03-31 $-0.09B $0.21B -48.79%
2012-12-31 $-0.08B $0.20B -52.01%
2012-09-30 $0.03B $0.15B 18.52%
2012-06-30 $-0.41B $0.15B -293.86%
2012-03-31 $-0.39B $0.15B -423.72%
2011-12-31 $-0.38B $0.14B -537.54%
2011-09-30 $-0.37B $0.12B -789.19%
2011-06-30 $0.08B $-0.03B 514.29%
2011-03-31 $0.09B $0.06B 472.73%
2010-12-31 $0.11B $0.04B -961.70%
2010-09-30 $0.13B $0.00B -271.58%
2010-06-30 $0.14B $-0.02B -174.39%
2010-03-31 $0.15B $-0.06B -123.73%
2009-12-31 $0.14B $-0.11B -91.12%
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $3.202B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.827B 10.78
Quest Diagnostics (DGX) United States $16.063B 16.60
DaVita (DVA) United States $11.923B 14.81
Encompass Health (EHC) United States $8.608B 22.03
Chemed (CHE) United States $8.132B 25.20
Elanco Animal Health (ELAN) United States $6.597B 17.11
Option Care Health (OPCH) United States $5.235B 19.82
RadNet (RDNT) United States $4.632B 96.45
Astrana Health (ASTH) United States $2.666B 36.05
Addus HomeCare (ADUS) United States $2.179B 28.20
LifeStance Health (LFST) United States $2.095B 0.00
U.S Physical Therapy (USPH) United States $1.424B 38.10
Pennant (PNTG) United States $0.789B 41.67
Aveanna Healthcare Holdings (AVAH) United States $0.677B 0.00
Atai Life Sciences (ATAI) Germany $0.270B 0.00
Daxor (DXR) United States $0.045B 0.00
ATI Physical Therapy (ATIP) United States $0.026B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.019B 0.00
Psychemedics (PMD) United States $0.013B 0.00
Ontrak (OTRK) United States $0.011B 0.00
Novo Integrated Sciences (NVOS) United States $0.011B 0.00
IMAC Holdings (BACK) United States $0.002B 0.00